Publications
Tissue Engineered Human Skeletal Muscle as a Pre-Clinical Model for AAV Treatment of Pompe Disease." In MOLECULAR THERAPY, S157. Vol. 22. 2014.
"Use of flow, electrical, and mechanical stimulation to promote engineering of striated muscles." Annals of biomedical engineering 42, no. 7 (2014): 1391-1405.
"Design considerations for an integrated microphysiological muscle tissue for drug and tissue toxicity testing." Stem Cell Res Ther 4 Suppl 1, no. Suppl 1 (2013).
"Engineering skeletal muscle repair." Current opinion in biotechnology 24, no. 5 (2013): 880-886.
"Induced pluripotent stem cell-derived cardiac progenitors differentiate to cardiomyocytes and form biosynthetic tissues." PloS one 8, no. 6 (2013): e65963.
"Spatial profiles of electrical mismatch determine vulnerability to conduction failure across a host-donor cell interface." Circulation. Arrhythmia and electrophysiology 6, no. 6 (2013): 1200-1207.
"Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes." Biomaterials 34, no. 23 (2013): 5813-5820.
"Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming." PloS one 8, no. 5 (2013): e63577.
"WNT3 is a biomarker capable of predicting the definitive endoderm differentiation potential of hESCs." Stem cell reports 1, no. 1 (2013): 46-52.
"Calcium dependent CAMTA1 in adult stem cell commitment to a myocardial lineage." PloS one 7, no. 6 (2012): e38454.
"Colonizing the heart from the epicardial side." Stem cell research & therapy 3, no. 2 (2012): 15.
"Conduction block in micropatterned cardiomyocyte cultures replicating the structure of ventricular cross-sections." Cardiovasc Res 93, no. 2 (2012): 263-271.
"Engineering an electromechanically functional 3d biosynthetic tissue using embryonic or induced pluripotent stem cells." In CIRCULATION, E735. Vol. 125. 2012.
"Functional cardiac tissue engineering." Regenerative medicine 7, no. 2 (2012): 187-206.
"Genetic engineering of somatic cells to study and improve cardiac function." Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 14 Suppl 5 (2012): v40-v49.
"Human Embryonic Stem Cell-Derived Cardiac Tissue Patch with Advanced Structure and Function." CIRCULATION 126, no. 21 (2012).
"Local tissue geometry determines contractile force generation of engineered muscle networks." Tissue engineering. Part A 18, no. 9-10 (2012): 957-967.
"Single-detector simultaneous optical mapping of V(m) and [Ca(2+)](i) in cardiac monolayers." Annals of biomedical engineering 40, no. 5 (2012): 1006-1017.
"Size and ionic currents of unexcitable cells coupled to cardiomyocytes distinctly modulate cardiac action potential shape and pacemaking activity in micropatterned cell pairs." Circulation. Arrhythmia and electrophysiology 5, no. 4 (2012): 821-830.
"Soluble miniagrin enhances contractile function of engineered skeletal muscle." FASEB journal : official publication of the Federation of American Societies for Experimental Biology 26, no. 2 (2012): 955-965.
"X-linked inhibitor of apoptosis protein-mediated attenuation of apoptosis, using a novel cardiac-enhanced adeno-associated viral vector." Hum Gene Ther 23, no. 6 (2012): 635-646.
"Engineering biosynthetic excitable tissues from unexcitable cells for electrophysiological and cell therapy studies." Nature communications 2 (2011): 300.
"FGF13 is a Regulator of the Cardiac Voltage-Gated Sodium Channel Nav1.5." In BIOPHYSICAL JOURNAL, 420-421. Vol. 100. 2011.
"Fibroblast growth factor homologous factor 13 regulates Na+ channels and conduction velocity in murine hearts." Circ Res 109, no. 7 (2011): 775-782.
"